Navidea Biopharmaceuticals Inc (NAVB)

[XJINVESTOR]

Should continue to trend upward. The guys thinking they could score an easy double in a few hours are gone.

For everyone who has been here longer than a couple months, you know this was the good news we needed. A couple months ago this went to 1.14 just on the RUMORS this news would come. This news should put us somewhere between 1.20 and 1.30 at a minimum.

The company has been very quiet on the newsfront and I think they have been waiting for this deal to go through before they move forward. They have a strong pipeline, BK is averted and all debts, specifically to CRG can be paid in full. Moving forward, they will collect a minimum of 20.1M per year over the next 3 years but could still collect 200M if sales of Lymphoseek skyrocket. Remember, they still collect on sales of Lymphoseek outside of the US and have concentrated marketing in Europe this quarter. We should hear how those sales have been going very soon!!

Anything under 1.00 is a steal here and look for a run up over 1.20-1.30 very soon!! GLTA